| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.51 | 0.06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |